Tag: Eli Lilly

Global Companies

Pharma Earnings Preview: Lilly, Merck, Gilead, AbbVie

Big pharma faces a wild Q3: booming weight loss drugs, slumping China sales, and Trump-era pricing twists. Will Lilly raise...

28/10/2025

5 views

Read More

Market News

AI Stocks Dip, Lilly Expands: Market Insights

Microsoft’s AI chip cooling breakthrough shakes stocks, while Eli Lilly’s $6.5B facility signals growth. What’s next for these markets? Dive...

23/09/2025

2 views

Read More

Growth Picks

Why Wells Fargo, Lilly, Boeing Are Hot Investment Picks

Wells Fargo’s bold moves, Lilly’s AI drug platform, and Boeing’s production spike are shaking up markets. What makes these stocks...

09/09/2025

5 views

Read More

Market News

Eli Lilly’s Obesity Pill: A New Weight Loss Contender

Eli Lilly’s new obesity pill could shake up the weight loss market, rivaling Novo Nordisk’s oral Wegovy. But what makes...

24/08/2025

2 views

Read More

Buying Opportunities

Insider Buying Signals Bright Future For Eli Lilly Stock

Eli Lilly's CEO and insiders are buying shares after a stock dip. Is this a golden opportunity for investors? Dive...

13/08/2025

4 views

Read More

Market News

Top 10 Stock Market Moves To Watch This Week

From Eli Lilly’s bold defense to Tesla’s major team shakeup, these 10 stock market moves are shaking things up. Want...

08/08/2025

2 views

Read More

Market News

Why Novo Nordisk’s GLP-1 Growth Is Slowing: Key Insights

Novo Nordisk’s Ozempic is losing ground in the GLP-1 market. What’s behind the slowdown, and can it recover? Dive into...

05/08/2025

10 views

Read More

Stocks

Why Health Care Stocks Are Poised For A June Rebound

Health care stocks crashed in May, but technical charts hint at a big June rebound. Can giants like Eli Lilly...

04/06/2025

9 views

Read More

Market News

What’s Fueling Tuesday’s Stock Surge and Lilly’s Defense

What's behind Tuesday's stock surge? From AI infrastructure to Eli Lilly's GLP-1 defense, uncover the market movers. Click to find...

03/06/2025

0 views

Read More

Market News

Why Weight Loss Drugs Spark Market Buzz

Eli Lilly’s obesity drug Zepbound faces a CVS-Wegovy deal. Will it shake their market lead? Dive into the drama...

07/05/2025

0 views

Read More